255 related articles for article (PubMed ID: 15606441)
21. CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians.
Vianna-Jorge R; Perini JA; Rondinelli E; Suarez-Kurtz G
Clin Pharmacol Ther; 2004 Jul; 76(1):18-26. PubMed ID: 15229460
[TBL] [Abstract][Full Text] [Related]
22. Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
Tornio A; Niemi M; Neuvonen PJ; Backman JT
Eur J Clin Pharmacol; 2007 May; 63(5):463-9. PubMed ID: 17333159
[TBL] [Abstract][Full Text] [Related]
23. Are cytochrome P450 CYP2C8 and CYP2C9 polymorphisms associated with ibuprofen response in very preterm infants?
Durrmeyer X; Hovhannisyan S; Médard Y; Jacqz-Aigrain E; Decobert F; Barre J; Alberti C; Aujard Y; Danan C; Baud O
PLoS One; 2010 Aug; 5(8):e12329. PubMed ID: 20808793
[TBL] [Abstract][Full Text] [Related]
24. CYP2C9 polymorphism in non-steroidal anti-inflammatory drugs-induced gastropathy.
Ma J; Yang XY; Qiao L; Liang LQ; Chen MH
J Dig Dis; 2008 May; 9(2):79-83. PubMed ID: 18419640
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography.
Teh LK; Zahri MK; Zakaria ZA; Ismail R; Salleh MZ
J Clin Pharm Ther; 2010 Dec; 35(6):723-8. PubMed ID: 21054465
[TBL] [Abstract][Full Text] [Related]
26. Effect of CYP2C9*3 allele on the pharmacokinetics of naproxen in Korean subjects.
Bae JW; Kim JH; Choi CI; Kim MJ; Kim HJ; Byun SA; Chang YS; Jang CG; Park YS; Lee SY
Arch Pharm Res; 2009 Feb; 32(2):269-73. PubMed ID: 19280158
[TBL] [Abstract][Full Text] [Related]
27. [Influence of cytochrom P450 CYP2C9 polymorphism on the pharmacokinetics of tolbutamide metabolism using oligonucleotide genotyping microarray].
Li J; Wen SY; Wang R; Chen K; Fang Y; Pei F; Wang SQ
Yao Xue Xue Bao; 2005 Aug; 40(8):695-9. PubMed ID: 16268502
[TBL] [Abstract][Full Text] [Related]
28. Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9.
Sachse-Seeboth C; Pfeil J; Sehrt D; Meineke I; Tzvetkov M; Bruns E; Poser W; Vormfelde SV; Brockmöller J
Clin Pharmacol Ther; 2009 Mar; 85(3):273-6. PubMed ID: 19005461
[TBL] [Abstract][Full Text] [Related]
29. Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies.
Sipeky C; Lakner L; Szabo M; Takacs I; Tamasi V; Polgar N; Falus A; Melegh B
Blood Cells Mol Dis; 2009; 43(3):239-42. PubMed ID: 19541511
[TBL] [Abstract][Full Text] [Related]
30. Characterizing the effect of cytochrome P450 (CYP) 2C8, CYP2C9, and CYP2D6 genetic polymorphisms on stereoselective N-demethylation of fluoxetine.
Wang Z; Wang S; Huang M; Hu H; Yu L; Zeng S
Chirality; 2014 Mar; 26(3):166-73. PubMed ID: 24464553
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.
Kudzi W; Dodoo AN; Mills JJ
BMC Med Genet; 2009 Dec; 10():124. PubMed ID: 19954515
[TBL] [Abstract][Full Text] [Related]
32. The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects.
Pedersen RS; Damkier P; Brosen K
Br J Clin Pharmacol; 2006 Dec; 62(6):682-9. PubMed ID: 16856883
[TBL] [Abstract][Full Text] [Related]
33. Effects of cytochrome P450 2C9 polymorphisms on phenprocoumon anticoagulation status.
Schalekamp T; Oosterhof M; van Meegen E; van Der Meer FJ; Conemans J; Hermans M; Meijerman I; de Boer A
Clin Pharmacol Ther; 2004 Nov; 76(5):409-17. PubMed ID: 15536456
[TBL] [Abstract][Full Text] [Related]
34. The association of CYP2C9 gene polymorphisms with colorectal carcinoma in Han Chinese.
Liao LH; Zhang H; Lai MP; Lau KW; Lai AK; Zhang JH; Wang Q; Wei W; Chai JH; Lung ML; Tai SS; Wu M
Clin Chim Acta; 2007 May; 380(1-2):191-6. PubMed ID: 17368604
[TBL] [Abstract][Full Text] [Related]
35. Haplotype structures of common variants of CYP2C8, CYP2C9, and ADRB1 genes in a South Indian population.
Arun Kumar AS; Chakradhara Rao US; Umamaheswaran G; Ramu P; Kesavan R; Shewade DG; Balachandar J; Adithan C
Genet Test Mol Biomarkers; 2011 Jun; 15(6):407-13. PubMed ID: 21375401
[TBL] [Abstract][Full Text] [Related]
36. Identification of a synonymous polymorphism within the cytochrome P4502C9 gene that interferes with identification of the CYP2C9*2 allele.
Womack EP; Reynolds KK; Valdes R; Linder MW
Ther Drug Monit; 2007 Oct; 29(5):607-11. PubMed ID: 17898651
[TBL] [Abstract][Full Text] [Related]
37. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
[TBL] [Abstract][Full Text] [Related]
38. Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension.
King LM; Gainer JV; David GL; Dai D; Goldstein JA; Brown NJ; Zeldin DC
Pharmacogenet Genomics; 2005 Jan; 15(1):7-13. PubMed ID: 15864120
[TBL] [Abstract][Full Text] [Related]
39. Allele and genotype frequencies of CYP2C9 in a Korean population.
Bae JW; Kim HK; Kim JH; Yang SI; Kim MJ; Jang CG; Park YS; Lee SY
Br J Clin Pharmacol; 2005 Oct; 60(4):418-22. PubMed ID: 16187974
[TBL] [Abstract][Full Text] [Related]
40. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
